In accordance with this finding, TNF blockade can prevent progressive joint damage in patients with RA who have a clinical response as well as in those who do (32, 33), and combination therapy of anti-RANKL monoclonal antibody and biological agents showed the efficacy on radiographic progression in RA (10). Here, TNFSF11 is linked to rheumatoid arthritis.